{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:37:13Z","timestamp":1790735833306,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmech.2022.114247","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T02:15:55Z","timestamp":1646792155000},"page":"114247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases"],"prefix":"10.1016","volume":"234","author":[{"given":"Baijayantimala","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-4584","authenticated-orcid":false,"given":"Santosh Kumar","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-8694","authenticated-orcid":false,"given":"Venkata Madhavi","family":"Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-5683","authenticated-orcid":false,"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114247_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114247_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/14756366.2013.787422","article-title":"Sulfa and trimethoprim-like drugs \u2013 antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors","volume":"29","author":"Capasso","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib4a","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib4b","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114247_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/molecules23010153","article-title":"Novel 6- and 7-substituted coumarins with inhibitory action against lipoxygenase and tumor-associated carbonic anhydrase IX","volume":"23","author":"Peperidou","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114247_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113486","article-title":"Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail\/dual tail approaches: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"221","author":"Eldeeb","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113490","article-title":"Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold","volume":"220","author":"Salerno","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib8","article-title":"Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases","volume":"188","author":"Khalil","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113351","article-title":"Comprehensive study on potent and selective carbonic anhydrase inhibitors: synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides","volume":"217","author":"Yamali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib10a","article-title":"Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide \u2013 a new caspase-activating proapoptotic agent","volume":"222","author":"Dar\u2019in","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib10b","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib11a","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2174\/138955709791012247","article-title":"Biological activities of quinoline derivatives","volume":"9","author":"Kumar","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib11b","first-page":"674","article-title":"Different biological activities of quinoline","volume":"9","author":"Raut","year":"2020","journal-title":"World J. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2022.114247_bib12","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0968-0896(99)00190-X","article-title":"Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic\/heterocyclic sulfonamide containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?","volume":"7","author":"Borras","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","article-title":"Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors","volume":"34","author":"Thacker","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib14","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/14756366.2019.1652282","article-title":"Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides AQ3 as carbonic anhydrase isoforms I and II inhibitors","volume":"34","author":"Al-Sanea","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011119","article-title":"Development of novel quinoline based sulfonamides as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"22","author":"Shaldam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114247_bib16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","article-title":"Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors","volume":"34","author":"Thacker","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104647","article-title":"Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors","volume":"108","author":"Singh","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115090","article-title":"Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors","volume":"27","author":"Swain","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bioorg.2018.10.064","article-title":"New quinoline\/chalcone hybrids as anti-cancer agents: design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity","volume":"82","author":"Abbas","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib20","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib21","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib22a","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/14756366.2013.879656","article-title":"Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors","volume":"30","author":"Korkmaz","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib22b","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/14756366.2014.892936","article-title":"Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme","volume":"30","author":"Akdemir","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib23a","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/14756366.2014.957202","article-title":"Inhibition studies of quinazoline-sulfonamide derivatives against the \u03b3-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis","volume":"30","author":"Alafeefy","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib23b","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/14756366.2014.963072","article-title":"Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors","volume":"30","author":"Darz","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114247_bib24","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jm501314c","article-title":"Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups","volume":"57","author":"Bozdag","year":"2014","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:56Z","timestamp":1759329536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"alternative-id":["S0223523422001490"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114247","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114247"}}